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AbstrACt
Introduction We describe the protocol for a project that 
will use linkage of routinely collected NHS data to answer 
a question about the nature and effectiveness of liaison 
psychiatry services in acute hospitals in England.
Methods and analysis The project will use three data 
sources: (1) Hospital Episode Statistics (HES), a database 
controlled by NHS Digital that contains patient data relating 
to emergency department (ED), inpatient and outpatient 
episodes at hospitals in England; (2) ResearchOne, a 
research database controlled by The Phoenix Partnership 
(TPP) that contains patient data relating to primary care 
provided by organisations using the SystmOne clinical 
information system and (3) clinical databases controlled 
by mental health trusts that contain patient data relating 
to care provided by liaison psychiatry services. We will 
link patient data from these sources to construct care 
pathways for patients who have been admitted to a 
particular hospital and determine those patients who have 
been seen by a liaison psychiatry service during their 
admission.
Patient care pathways will form the basis of a matched 
cohort design to test the effectiveness of liaison 
intervention. We will combine healthcare utilisation within 
care pathways using cost figures from national databases. 
We will compare the cost of each care pathway and the 
impact of a broad set of health- related outcomes to obtain 
preliminary estimates of cost- effectiveness for liaison 
psychiatry services. We will carry out an exploratory 
incremental cost- effectiveness analysis from a whole 
system perspective.
Ethics and dissemination Individual patient consent 
will not be feasible for this study. Favourable ethical 
opinion has been obtained from the NHS Research Ethics 
Committee (North of Scotland) (REF: 16/NS/0025) for 
Work Stream 2 (phase 1) of the Liaison psychiatry—
measurement and evaluation of service types, referral 
patterns and outcomes study. The Confidentiality Advisory 
Group at the Health Research Authority determined that 
Section 251 approval under Regulation 5 of the Health 
Service (Control of Patient Information) Regulations 2002 
was not required for the study ‘on the basis that there is 
no disclosure of patient identifiable data without consent’ 
(REF: 16/CAG/0037).
Results of the study will be published in academic journals 
in health services research and mental health. Details 
of the study methodology will also be published in an 
academic journal. Discussion papers will be authored for 
health service commissioners.
IntroduCtIon
Liaison psychiatry services provide assess-
ment and treatment for people with coexis-
tent physical and mental health problems.1–4 
Such services are provided predominantly in 
the acute hospital setting in the UK, although 
more recently services have emerged to 
support the management of people with 
complex physical and mental health prob-
lems in primary as well as secondary care.5 
Liaison psychiatry services have the poten-
tial to improve both the quality of care and 
overall outcomes for people with mental 
and physical health problems. There is also 
strengths and limitations of this study
 ► Study designs based on the linkage of routinely col-
lected NHS data enable the generation of evidence 
regarding the cost- effectiveness and efficiency of 
health services, where alternative study designs 
such as randomised controlled trails or other individ-
ually consented study designs would be infeasible.
 ► While our study will evaluate the impact of acute 
inpatient hospital work carried out by liaison psychi-
atry teams and will not cover work undertaken in the 
emergency department, outpatient or primary care 
setting, the findings will be highly relevant, as previ-
ous claims for cost savings resulting from the imple-
mentation of liaison psychiatry services have been 
primarily based on their inpatient hospital work.
 ► Study designs based on the linkage of routinely col-
lected NHS data present technical, ethical and legal 
challenges which must be considered from the start, 
including their implications for the validity and gen-
eralisability of insights and for project resources.
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a suggestion that liaison psychiatry services in the acute 
hospital setting will produce cost savings by reducing 
length of stay, even though it is estimated that services 
see a small proportion (1%–5%) of all patients admitted 
to acute beds.6–12 For these reasons, NHS England has 
invested in expanding liaison psychiatry services to acute 
hospitals.13 14
The research evidence has not been strong for the 
cost- effectiveness of liaison psychiatry services15 16 as 
opposed to evidence on the cost- effectiveness of some 
of the individual interventions used in those services.17 18 
For that reason, more research is needed using robust 
designs derived from health services research. Claims 
for cost- effectiveness of liaison psychiatry go to the 
origins of the specialty before World War II. Individual 
components have been tested in randomised controlled 
trials (RCTs), but there have been few attempts to judge 
the cost- effectiveness of whole services. Although it has 
been argued that they can pay for themselves—the cost- 
offset debate of the 1980 and 1990s19—in truth, the cost- 
effectiveness evidence for any liaison psychiatry service 
is limited. Holmes et al20 identified only two RCTs; some 
smaller non- randomised studies include working age 
and older patients, and older and non- definitive work on 
cost- offsetting.
There are three main reasons why visiting the question 
now is timely.
First, cost pressures in the NHS and the emergence of 
commissioning led by Clinical Commissioning Groups 
will continue to lead to re- profiling of services and espe-
cially attempts to reduce unnecessary hospital costs. 
Work on developing and implementing risk stratifica-
tion models is an illustration and it is interesting that 
many of these models identify comorbid physical and 
mental health problems as a risk, both for increased 
healthcare costs and for the main driver of such costs 
which is unscheduled hospital admission. A study 
from Birmingham describing the evaluation of a rapid 
assessment, intervention and discharge service (previ-
ously widely known by the acronym RAID) was widely 
promoted and is leading to commissioning of similar 
services that will be hoped to reduce costs.21 22 There 
were however substantial problems with that evaluation: 
it reported only on the first 9 months of delivery of a 
new service; it used a simple before and after design; 
it compared outcomes between referred and a matched 
group of non- referred patients in only 79 cases with 
minimal matching that cannot have dealt with indica-
tion bias and much of the benefit was attributed to the 
so- called indirect liaison cases who were in fact not seen 
by the service but assumed to benefit by its existence 
in the hospital. Other ‘RAID’-like services have also 
reported large savings in cost or reductions in hospital 
use following implementation.23 24 So a key answer to 
the question of why this research is needed now is the 
pressing need to confirm or refute the very striking 
claims made for similar services, but using larger 
numbers and more robust research methods.
Second, there is a danger of losing sight of the other 
main functions of liaison psychiatry services, which do 
not exist only to reduce costs in the general hospital but 
which are aimed at improving the well- being of patients, 
some of whom are being treated entirely or appropri-
ately in the general hospital and happen to need mental 
health service input because of the complexity of their 
problems.
Third, and related to the second point above, service 
commissioning and provision will benefit from a more 
standardised approach to service descriptors. Without 
more detailed knowledge about how to define the service 
being commissioned and how to evaluate whether it is 
working to remit and to improve Health- Related Quality 
of Life for patients, there is a risk of enthusiastic commis-
sioning of services that look superficially similar to each 
other and to a model reported as cost- effective, when in 
fact either at the time or over a period after commissioning 
there are differences in staffing or referral patterns that 
invalidate the original commissioning assumptions. An 
important function is served by studies that describe what 
patient groups actually receive—what sort of service and 
in what numbers.
This research is thus timely in exploring methods to 
evaluate the function and performance of liaison psychi-
atry services.
There are, however, challenges in conducting such 
research.
First, defining exposure to liaison psychiatry is difficult 
because there is substantial heterogeneity in the compo-
sition, purpose and size of liaison psychiatry services. For 
example, a recent survey conducted in England25 found 
that just over half of the services provided a 24- hour 7- day 
service and only one- third ran specialist outpatient clinics. 
Most of the services provided cover of acute hospital wards 
and emergency department (ED) and nearly all services 
were multidisciplinary, but staff mix varied such that about 
one- third employed less than one full- time equivalent of 
a consultant in psychiatry. Only one- third of services had 
separate teams for older adults and adults of working age. 
These differences were not fully explained by variation 
in acute hospital characteristics. Also, the mechanism by 
which liaison psychiatry services might produce improved 
patient and organisational outcomes is unclear—for 
example, with some suggesting that the main benefit is 
by securing rapid discharge to community- based services, 
while others emphasise the specialist nature of shared 
inpatient management or of outpatient clinics provided 
by the service.
Second, defining service outcomes is difficult because 
there is also substantial heterogeneity in the patient 
populations seen in liaison psychiatry services. For 
example, service outcomes (and performance indica-
tors) will not be the same for somebody seen in the ED 
after an act of self- harm, an older person with postop-
erative agitated behaviour seen on a surgical ward or 
somebody with chronic unexplained pain referred from 
a pain clinic.
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To evaluate the impact of liaison psychiatry services 
on the outcomes of patients in acute hospital settings, 
we therefore need to be able to do three things. Patients 
attending selected hospitals need to be characterised 
with respect to their physical and mental health. The 
prognosis for any given mental health problem is strongly 
influenced by the prior history of mental disorder, so the 
nature of the psychiatric problem needs to be described 
not just at the time of admission but in the preceding 
months. This longitudinal picture can only be determined 
reliably and for all patients in any sample by the use of 
routine data from primary care. Patient healthcare contact 
in both primary and secondary care services needs to be 
recorded. And outcomes need to be identified beyond the 
immediate spell in hospital. The heterogeneity of both 
patient population and service exposures requires a large 
study in terms of number of hospitals and patients.
In addition to these measurement problems, there is 
a challenge in choosing a robust research design. There 
have been several RCTs showing the effectiveness of indi-
vidual components of liaison psychiatry services, but an 
individually randomised RCT of a whole service config-
uration would be impractical. The heterogeneity of case mix 
even in simpler services will require numbers beyond what 
could be reasonably recruited, and there are major chal-
lenges in obtaining a large representative sample when 
individual consent is required. Because many patients 
seen by liaison psychiatry services lack mental capacity 
at the time of service contact, an individually consented 
study is not feasible and an individually RCT study would 
not in any case answer the service- level question.
We also considered a cluster RCT of different liaison 
psychiatry services. Heterogeneity of service provision, as iden-
tified in our national survey of services in England, would 
make such a study prohibitively large.
For these reasons, our view is that a large- scale observa-
tional study based on analysis of routinely collected NHS data 
and which is not predicated on individual patient consent 
is the best option.
MEthods And AnAlysIs
study design
Retrospective cohort design, comparing outcomes for 
patients admitted to hospital and seen by a liaison psychi-
atry service with two control groups—the first is a patient 
group who were admitted to the same hospital in the 
same study period and matched on hospital inpatient 
and primary care data, but were not seen by the liaison 
psychiatry service. Because such a design could not 
entirely exclude confounding by indication, we will use 
a second matched patient group who had been admitted 
to a different hospital without a liaison psychiatry service 
in the same study period. This second group will also 
be matched using data from hospital and primary care 
records; however, they will not have been selected on the 
basis of whether the responsible (acute hospital) consul-
tant had made a decision about liaison psychiatry referral.
Aims and objectives
This study arises from a commissioning call by the UK’s 
National Institute for Health Research and represents 
one component (Work Stream 2) of the wider project, 
LP- MAESTRO,26 which is designed to evaluate the cost- 
effectiveness and efficiency of liaison psychiatry service 
provision in the UK. The aim of the study described in 
this paper is to examine care pathways for the main target 
populations of liaison psychiatry services and estimate the 
outcomes and costs associated with care. Specifically, we 
will:
1. Use routinely collected NHS data to identify patients 
referred to specific liaison psychiatry services and 
matched comparison patients who were not referred, 
with the aim of comparing within and between hos-
pitals the effect of referral or non- referral of patients 
with similar characteristics.
2. Estimate the cost of the care pathways of patients re-
ferred to liaison psychiatry services, and the matched 
comparison patient groups, and the main determi-
nants of those costs over 12 months after an index hos-
pital episode.
We will characterise patients according to their contact 
with liaison psychiatry service, for example reason for 
referral, scheduled or urgent referral and mental health 
diagnosis. We will determine those patients who were 
referred to liaison psychiatry services from acute (general 
hospital) sources, and a matched sample of cases 
from the same sources who were not referred. We will 
compare outcomes for certain marker conditions (such 
as mental–physical comorbidity, acute behavioural distur-
bance, cognitive impairment/dementia) in different 
liaison psychiatry service configurations.
data sources
Patient data that are relevant to the study are routinely 
collected by clinicians and healthcare professionals 
to inform patient care. Such data are collected inde-
pendently by the organisations that provide different 
services to patients, and only those variables that are 
required to fulfil the purpose(s) of these services are 
included. A limited number of standardised data sets 
are collected from organisations that provide care and 
are aggregated at national- level by organisations, such 
as NHS Digital. Some of these data sets (or derivatives) 
are made available for research purposes. However, no 
single organisation can currently provide the data that 
are required for the study, so linkage is essential.
Hospital Episode Statistics (HES)27 is a database 
controlled by NHS Digital that contains patient data 
relating to ED, inpatient and outpatient episodes for 
NHS hospitals in England. Episodes represent discrete 
periods of care under a particular consultant. Episodes 
can be combined into spells to represent the period of 
care from admission to discharge. HES is derived from 
the Commissioning Data Set,28 which is supplied to NHS 
Digital by organisations that provide NHS services to 
facilitate monitoring and payment. Patients can opt- out 
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of the inclusion of their confidential patient information in 
data sets which are made available by NHS Digital for 
purposes beyond care, such as HES, through the national 
opt- out programme.29 HES is an important source of 
data relating to health service interaction in secondary 
care. There are three significant limitations that are rele-
vant to this study.
First, referral to liaison psychiatry services cannot be 
reliably determined from HES. A new episode is not 
generated by such a referral—the patient remains within 
the care of the acute hospital consultant—and contact 
with a different consultant- led team in liaison psychiatry 
is not represented within an episode.
Second, it is suggested that mental health diagnoses 
recorded in routinely collected NHS data, such as 
HES, exhibit variable accuracy with respect to the true 
diagnosis.30
Third, patient interactions with primary care services 
are not included in HES. Such data are required to match 
patients by defined characteristics and to determine the 
care delivered in primary care following a general hospital 
admission that leads to a liaison psychiatry referral.
To address the first limitation, clinical databases 
controlled by the mental health trusts that provide liaison 
psychiatry services will be used. Such databases contain 
patient data relating to care provided by liaison psychiatry 
services and can be used in conjunction with HES data 
to determine whether a patient was referred to a liaison 
psychiatry service during a hospital admission. The 
main challenges with the use of such databases are data 
quality and the heterogeneous processes by which data 
access is negotiated and administered within different 
organisations.
To address the second and third limitation, data 
relating to primary care is required for each patient. 
Although the Clinical Practice Research Datalink data-
base31 is widely used for primary care research in the UK, 
it has a major drawback for this study—limited numbers 
and geographical coverage of participating primary care 
organisations at the time of study design. Instead Resear-
chOne,32 a research database controlled by The Phoenix 
Partnership (TPP), will be used. ResearchOne contains 
patient data relating to primary care provided by organi-
sations using the SystmOne clinical information system.33 
SystmOne (34%) and EMIS34 (56%) are the most preva-
lent clinical information systems used by organisations in 
general practice.35 Therefore, many of the patients with 
episodes in the HES data can be expected to have data 
relating to their primary care collected by organisations 
that use SystmOne. ResearchOne contains data for a 
subset of these patients—patients who: (1) are registered 
to organisations that use SystmOne and have opted- in to 
participation in ResearchOne and (2) have not individu-
ally opted- out of participation in ResearchOne. The main 
challenge with the use of ResearchOne is the inability 
to determine a priori the numbers and geographical 
coverage of organisations that provide primary care to 
patients attending the hospitals chosen for the study, and 
the resultant ability to match HES data to corresponding 
ResearchOne data for each patient.
Patient data from these three sources will be linked to 
construct patient care pathways that span primary and 
secondary care settings. Linkage will be undertaken by 
NHS Digital. Each data source will generate two unique 
references for each patient: (1) a pseudonym—gener-
ated by applying a one- way cryptographic hash function 
(SHA-512) to an input that comprises a cryptographic 
salt and their NHS number and (2) a source- specific 
identifier. For a patient with a given NHS number, each 
data source will generate the same pseudonym but a 
different source- specific identifier. Both the pseudonym 
and source- specific identifier generated for each patient 
will be specific to the study. Pseudonyms will be used by 
NHS Digital to: (1) communicate to data sources of those 
patients for whom data are required and (2) generate 
mappings between different source- specific identifiers 
for each patient. Data sources will provide the required 
patient data to the research team, including only the 
source- specific identifier as the unique reference for each 
patient. The mappings generated by NHS Digital will be 
provided to the research team and used to determine the 
data that relate to each patient across the data received 
from different sources.
data extraction
Based on the results from earlier stages of the LP 
MAESTRO project, we will identify at least two and up to 
six configurations that best represent patterns of liaison 
psychiatry service across England. Defining features of 
such configurations will include, for example, staff mix, 
availability of specialist teams (eg, age- related, self- harm), 
hours of service provided by the specialist team and 
source of referrals (predominantly ED, predominantly 
ward, specialist services and so on). We will sample purpo-
sively to obtain 2–4 services of each type (depending on 
availability). Data will be extracted for patients attending 
the hospitals with these service elements in a 1- year index 
period and also for patients attending hospitals identi-
fied as not having a liaison psychiatry service in the same 
period. Financial year 2013–2014 was selected as the 
index period as it represented the latest complete year 
for which data was available from NHS Digital at the time 
of study design. Numbers of accident and emergency 
(A&E) attendances and inpatient admissions in the index 
period to estimate sample size are not publicly available at 
hospital level. However, numbers are published by NHS 
Digital at trust level,36 37 where one trust operates one or 
more hospitals. These trust- level figures provide an indic-
ative upper bound on the A&E attendances and inpatient 
admissions that can be expected at any hospital operated 
by that trust in a given year.
Relevant variables extracted for each patient from 
the sources will include demographic variables (eg, age, 
carer support, index of multiple deprivation—a measure 
of locality deprivation), clinical variables (eg, diagnosis, 
medications) and health service utilisation variables 
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(eg, inpatient days, general practitioner (GP) appoint-
ments, major procedures). One of the novelties of our 
approach is the use of variables obtained from primary 
and secondary care settings to tackle the substantial chal-
lenge that comes from indication bias; for example, we 
will use variables obtained from ResearchOne to define 
healthcare usage in primary care for the year before 
referral (2013), as a way of ensuring that outcomes in the 
year after referral (2015) are not attributed to easily iden-
tifiable pre- existing characteristics (case complexity) that 
are confounded with likelihood of referral.
Patient care pathways for patients attending hospitals 
using liaison psychiatry services in each configuration will 
be constructed to provide a view of health and health-
care across both primary and secondary care. Pathways 
will be constructed for patients for a period of 12 months 
following their index (first) hospital admission in the 
index period. The cost of each pathway to the healthcare 
sector will then be calculated using national data sources 
(see below). We will adopt a whole system perspective in 
order to determine if there is an association between the 
configuration of liaison psychiatry services and health-
care utilisation by patients. Metrics including emergency 
admissions, occupied bed days and length of stay will be 
analysed by age band.
data analysis
We will build a standard regression model to estimate the 
relation between healthcare utilisation and key variables 
capturing the configuration of liaison psychiatry services. 
The dependent variable in this model will therefore be the 
total costs of any identified healthcare utilisation derived 
from factors such as inpatient days, readmission rates, 
ED attendances and GP visits combined with reference 
costs. These reference costs will be valued using national 
sources, including the Department of Health Reference 
Costs38 and Personal Social Services Research Institute 
Costs for Health and Social Care.39 Where these are not 
available, local costs will be assigned. We will choose the 
most appropriate base year for the analysis and adjust 
appropriately for the effects of inflation across years. The 
quantum of the liaison psychiatry service provision will 
be captured by already collected data related to structure 
and process, for example, staffing levels and contact time 
after referral. We will adjust for referral indication bias, 
either by matching for covariates or by propensity scoring.
Sample size is difficult to estimate because we have 
so little available data on outcomes for different service 
types and different patient groups. Suppose we identify 
six main service configurations and recruit two liaison 
psychiatry services for each (total n=12). For less common 
conditions we might expect to see one referral per week 
per service=100 in total in the year. For more common 
conditions we might perhaps see one referral per day or 
600–800 in the year. These numbers will allow us to esti-
mate the costs and cost- effectiveness of liaison psychiatry 
services with substantially greater precision than has been 
achieved to date, for example, by the RAID evaluation.
The way in which components of general hospital, 
general mental health and liaison psychiatry services 
interact with each other is complex and a key part of the 
project will be to determine how to capture this complexity 
into a set of measures for inclusion in the model.
We (CH, ST) will carry out exploratory incremental 
cost- effectiveness analyses using decision analysis model-
ling. The model will rely on the retrospectively estimated 
healthcare costs of alternative care pathways and the char-
acteristics at hospital, service and patient level. Given the 
nature of the data available, the absence of measures such 
as Quality of Life measures and the heterogeneous nature 
of the population, we will explore the use of a range of 
variables to assess effectiveness and evaluate the costs per 
length of stay, per re- admission and per life years lost. 
The health economics analyses will be informed by earlier 
work packages in the Liaison psychiatry—measurement 
and evaluation of service types, referral patterns and 
outcomes (LP- MAESTRO) project. However, we will 
also follow the guidance from the National Institute for 
Clinical Excellence (NICE) for methods for technology 
appraisal.40 While it is clear that some aspects of an 
exploratory model (or indeed models) may be specified 
in advance, for example, the perspective of the economic 
evaluation which will be the health service provider and 
the comparator which will be usual care, other aspects 
will be dependent on the shape of the services and the 
populations they engage with.
At this point we are unable to specify the time horizon 
of the decision analysis model evaluating the long- term 
cost- effectiveness of liaison psychiatry services. We will 
look to a long- term model and use NICE recommended 
discount rates for costs. The model itself is likely to be 
Markov or semi- Markov. Sensitivity analyses will be under-
taken in line with those recommended for this type of 
modelling.41 Presentation of the analysis or analyses 
will include incremental cost- effectiveness ratios, cost- 
effectiveness acceptability curves and net monetary 
benefit estimates. In addition, we will undertake a value 
of information analysis.42
Patient and public involvement
The study has a patient and public involvement represen-
tative on the Study Steering Committee that oversees the 
management of the research.
EthICs And dIssEMInAtIon
The study is funded by the National Institute of Health 
Research under the Health Services and Delivery 
Research programme (REF: 13/58/08) and is sponsored 
by the University of Leeds. The study is based at the Leeds 
Institute of Health Sciences within the University of Leeds 
and will use the Information Governance Toolkit (IGT) 
compliant infrastructure at the Leeds Institute of Clini-
cial Trials Research (REF: ECC0010).
To simplify the documentation provided to underpin 
ethics and governance processes, the study has been 
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partitioned into distinct phases. Each phase is character-
ised by the use of a specific combination of data sources 
to construct care pathways for patients attending a partic-
ular hospital or set of hospitals. Phase 1 is characterised 
by the use of data from HES and ResearchOne only to 
construct care pathways for patients attending hospitals 
without a liaison psychiatry service. A summary of the 
ethics and governance processes undertaken for phase 1 
is provided below.
As described in the Introduction section, individual 
patient consent will not be feasible for this study.
Phase 1 was submitted to the NHS Research Ethics 
Committee (North of Scotland) on 23 February 2016 
(REF: 16/NS/0025). The application was reviewed in a 
meeting held on 10 March 2016 and received a favour-
able ethical opinion on 15 March 2016. Favourable 
ethical opinion was contingent in obtaining management 
permission from the hospitals whose patients were to be 
included in the HES data. Management permission was 
received for 8 of the 11 hospitals by a stated deadline (15 
December 2016) and phase 1 proceeded based on the use 
of HES data from these eight hospitals only.
Phase 1 was also submitted to the Confidentiality Advi-
sory Group (CAG)43 at the Health Research Authority 
on 23 February 2016 (REF: 16/CAG/0037) to determine 
whether the study required Section 251 support under 
Regulation 5 of the Health Service (Control of Patient 
Information) Regulations 2002.44 The application was 
reviewed in a meeting on 21 April 2016 and was deferred 
pending the receipt of further information in relation 
to the linkage process from the research team. Further 
information was supplied and CAG provided a decision 
on 19 July 2016 that Section 251 support was not required 
‘on the basis that there is no disclosure of patient identifi-
able data without consent’.
Based on favourable ethical opinion and a decision 
from CAG that Section 251 support was not required, 
approval in principle for phase 1 was provided by TPP on 
11 October 2016. Data requests were submitted to NHS 
Digital on 16 December 2016 (REF: NIC-77953) and 
TPP on 22 February 2017. Supporting evidence docu-
ments were provided with these requests, which included 
confirmation of favourable ethical opinion, confirmation 
of the CAG decision on Section 251 support and details 
of the technical and organisational safeguards in place 
at the data controller and processors. Organisational 
safeguards included a Data Processing Agreement estab-
lished between University of Leeds and TPP to cover the 
data processing activities within phase 1. The applica-
tion was reviewed by the Independent Group Advising 
on the Release of Data (IGARD)45 at NHS Digital on 20 
March 2018. Further information was requested from the 
project team by IGARD, which was subsequently supplied, 
and a recommendation to approve the application was 
provided in a meeting on 26 April 2018. A Data Sharing 
Agreement was established between the University of 
Leeds and NHS Digital for phase 1 on 26 April 2018, 
which was underpinned by the pre- existing Data Sharing 
Framework Contact between the University of Leeds and 
NHS Digital (REF: CON-315426- K3W7R).
Data were supplied by NHS Digital on 16 November 
2018 and the remaining data from NHS Digital and TPP 
are currently awaited.
Results of the study will be published in academic jour-
nals in health services research and mental health. Details 
of the study methodology will also be published in an 
academic journal. Discussion papers will be authored for 
health service commissioners.
dIsCussIon
Studies based on the linkage of routinely collected NHS 
data enable the generation of evidence regarding the 
cost- effectiveness and efficiency of health services, where 
alternative study designs such as RCTs or other individu-
ally consented study designs would be infeasible. Health 
service commissioners can be provided with robust 
evidence to underpin decisions regarding health services 
and interventions—in this case relating to the cost- 
effectiveness and efficiency of different liaison psychiatry 
configurations for specified target populations—where 
previously there may have been limited or no evidence. 
The findings of this study will evaluate the impact of acute 
inpatient hospital work carried out by liaison psychiatry 
teams, and does not cover work undertaken in the ED, 
outpatient or primary care setting. The findings, however, 
will be highly relevant, as previous claims for cost savings 
resulting from the implementation of liaison psychiatry 
services have been primarily based on their inpatient 
hospital work.
Studies such as this present technical, ethical and legal 
challenges. Study designs should consider such challenges 
from the start, including their implications for the validity 
and generalisability of insights and for project resources. 
Experience from LP- MAESTRO demonstrates that signif-
icant resources are required to design and communi-
cate a research protocol in the manner that satisfies 
the different project stakeholders, including research 
ethics committees, data controllers, regulatory bodies 
and data access committees. Different stakeholders are 
focused on their specific remit and require communi-
cation of the research protocol in accordance with that 
remit. Moreover, different stakeholders may comprise of 
decision makers from different disciplines and require 
the research protocol to be communicated at differing 
levels of abstraction to ensure adequate comprehension. 
This issue of communication between disciplines and the 
potential for misinterpretation is highlighted in a recent 
Nuffield Foundation report.46
The project described here is both technically feasible 
and consistent with current legislative and ethical frame-
works applicable to the use of health data for research 
purposes. The main practical challenges reside in the 
communication with, negotiation between and coordina-
tion of different stakeholders as outlined earlier.
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There are potential limitations to the findings: it may 
not be easy to derive clearly discrete configurations of 
service from routinely available data; although matching 
via primary care records will allow more precision than 
can be managed from routine hospital data, the data 
available for matching will still be limited and not stan-
dardised across records; although a multi- site study will 
generate substantial numbers (a typical liaison psychiatry 
service will make 2000+ new contacts a year), sample sizes 
for particular subgroups of patients may be too small for 
meaningful analysis.
Author affiliations
1Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, 
UK
2National Inpatient Centre for Psychological Medicine, Leeds and York Partnership 
NHS Foundation Trust, Leeds, UK
3Centre for Psychiatry, Department of Medicine, Imperial College London, London, 
UK
4College Centre for Quality Improvement, Royal College of Psychiatrists, London, UK
5Veterans and Families Institute for Military Research, Faculty of Health, Social Care 
and Education, Anglia Ruskin University, Chelmsford, UK
6University of Exeter Medical School, College of Medicine and Health, University of 
Exeter, Exeter, UK
7Institute of Health and Society, Université catholique de Louvain, Louvain- la- Neuve, 
Belgium
Acknowledgements The views expressed are those of the author(s) and not 
necessarily those of the National Institute for Health Research (NIHR) or the 
Department of Health and Social Care.
Contributors CS, JH, RMW, EG, PT, MJC, CJCM, MF, CH, ST and AH contributed 
to the design of the study protocol. AH, JH and CS authored the manuscript. CS, 
JH, RMW, EG, PT, MJC, CJCM, MF, CH, ST and AH contributed to the revision of the 
manuscript and approved the final version.
Funding This project is funded by the National Institute for Health Research (NIHR) 
Health Services and Delivery Research (HS&DR) programme (project reference 
13/58/08).
Competing interests CS is Director of PrivacyForge Limited. All other authors 
declare that they have no competing interests.
Patient consent for publication Not required.
Ethics approval Individual patient consent will not be feasible for this study. 
Favourable ethical opinion has been obtained from the NHS Research Ethics 
Committee (North of Scotland) (REF: 16/NS/0025) for Work Stream 2 (phase 1) of 
the Liaison psychiatry—measurement and evaluation of service types, referral 
patterns and outcomes study. The Confidentiality Advisory Group at the Health 
Research Authority determined that Section 251 approval under Regulation 5 of the 
Health Service (Control of Patient Information) Regulations 2002 was not required 
for the study ‘on the basis that there is no disclosure of patient identifiable data 
without consent’ (REF: 16/CAG/0037).
Provenance and peer review Not commissioned; externally peer reviewed.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
orCId ids
Elspeth Guthrie http:// orcid. org/ 0000- 0002- 5834- 6616
Allan House http:// orcid. org/ 0000- 0001- 8721- 8026
rEFErEnCEs
 1 Aitken P, Lloyd G, Mayou R, et al. A history of liaison psychiatry in the 
UK. BJPsych Bull 2016;40:199–203.
 2 Lipowski ZJ. Consultation- liaison psychiatry: the first half century. 
Gen Hosp Psychiatry 1986;8:305–15.
 3 Mayou R. The history of General Hospital psychiatry. Br J Psychiatry 
1989;155:764–76.
 4 Schwab JJ. Consultation- liaison psychiatry: a historical overview. 
Psychosomatics 1989;30:245–54.
 5 Bestall J, Siddiqi N, Heywood- Everett S, et al. New models of care: 
a liaison psychiatry service for medically unexplained symptoms and 
frequent attenders in primary care. BJPsych Bull 2017;41:340–4.
 6 Huyse FJ, Herzog T, Lobo A, et al. European consultation- liaison 
services and their user populations: the European consultation- 
liaison Workgroup collaborative study. Psychosomatics 
2000;41:330–8.
 7 Diefenbacher A. Implementation of a psychiatric consultation 
service: a single- site observational study over a 1- year- period. 
Psychosomatics 2001;42:404–10.
 8 Christodoulou C, Fineti K, Douzenis A, et al. Transfers to psychiatry 
through the consultation- liaison psychiatry service: 11 years of 
experience. Ann Gen Psychiatry 2008;7.
 9 Su J- A, Chou S- Y, Chang C- J, et al. Changes in consultation- liaison 
psychiatry in the first five years of opearation of a newly- opened 
hospital. Chang Gung Med J 2010;33:292–300.
 10 Sánchez- González R, Rodríguez- Urrutia A, Monteagudo- Gimeno 
E, et al. Clinical features of a sample of inpatients with adjustment 
disorder referred to a consultation- liaison psychiatry service over 
10 years. Gen Hosp Psychiatry 2018;55:98–9.
 11 Sánchez- González R, Baillès- Lázaro E, Bastidas- Salvadó A, 
et al. Clinical profile of inpatients referred to a consultation- liaison 
psychiatry service: an observational study assessing changes over a 
10- yearperiod. Actas Esp Psiquiatr 2018;46:58–67.
 12 Gala C, Rigatelli M, De Bertolini C, et al. A multicenter investigation 
of consultation- liaison psychiatry in Italy. Italian C- L group. Gen Hosp 
Psychiatry 1999;21:310–7.
 13 NHS England. Five year forward view. London: NHS England, 2014.
 14 NHS England. Urgent and emergency mental health liaison in acute 
hospitals (adult and older adults): supporting documentation for 
transformation funding selection. London: NHS England, 2016.
 15 Andreoli PBdeA, Citero VdeA, Mari JdeJ. A systematic review of 
studies of the cost- effectiveness of mental health consultation- liaison 
interventions in general hospitals. Psychosomatics 2003;44:499–507.
 16 Hosaka T, Aoki T, Watanabe T, et al. General Hospital psychiatry 
from the perspective of medical economics. Psychiatry Clin Neurosci 
1999;53:449–53.
 17 Ruddy R, House A. Meta- review of high- quality systematic reviews 
of interventions in key areas of liaison psychiatry. Br J Psychiatry 
2005;187:109–20.
 18 Wood R, Wand APF. The effectiveness of consultation- liaison 
psychiatry in the General Hospital setting: a systematic review. J 
Psychosom Res 2014;76:175–92.
 19 Strain JJ, Hammer JS, Fulop G. APM Task force on psychosocial 
interventions in the General Hospital inpatient setting. A review of 
cost- offset studies. Psychosomatics 1994;35:253–62.
 20 Holmes A, Handrinos D, Theologus E, et al. Service use in 
consultation- liaison psychiatry: guidelines for baseline staffing. 
Australas Psychiatry 2011;19:254–8.
 21 Parsonage M, Fossey M. Economic evaluation of a liaison psychiatry 
service. London: Centre for Mental Health, 2011.
 22 Tadros G, Salama RA, Kingston P, et al. Impact of an integrated rapid 
response psychiatric liaison team on quality improvement and cost 
savings: the Birmingham raid model. Psychiatrist 2013;37:4–10.
 23 Becker L SR, Hardy R, Pilling S. The raid model of liaison psychiatry: 
report on the evaluation of four pilot services in East London. 
London: UCL Partners Academic Health Science Partnership, 2016.
 24 Opmeer BC, Hollingworth W, Marques EMR, et al. Extending the 
liaison psychiatry service in a large hospital in the UK: a before and 
after evaluation of the economic impact and patient care following 
ED attendances for self- harm. BMJ Open 2017;7:e016906.
 25 Walker A, Barrett JR, Lee W, et al. Organisation and delivery of 
liaison psychiatry services in general hospitals in England: results of 
a national survey. BMJ Open 2018;8:e023091.
 26 National Institute for Health Research (NIHR). Liaison psychiatry: 
measurement and evaluation of service types, referral patterns 
and outcomes (LP- MAESTRO), 2019. Available: https://www. 
journalslibrary. nihr. ac. uk/ programmes/ hsdr/ 135808 [Accessed 19 
Feb 2019].
 27 NHS Digital. Hospital Episode Statistics (HES), 2019. Available: 
https:// digital. nhs. uk/ data- and- information/ data- tools- and- services/ 
data- services/ hospital- episode- statistics [Accessed 19th Feb 2019].
 28 NHS Digital. Commissioning datasets, 2019. Available: https:// digital. 
nhs. uk/ data- and- information/ data- collections- and- data- sets/ data- 
sets/ commissioning- data- sets
copyright.
 o
n
 January 13, 2020 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032179 on 24 November 2019. Downloaded from 
8 Smith C, et al. BMJ Open 2019;9:e032179. doi:10.1136/bmjopen-2019-032179
Open access 
 29 NHS Digital. National Opt- Out programme, 2019. Available: https:// 
digital. nhs. uk/ services/ national- data- opt- out- programme [Accessed 
19th Feb 2019].
 30 Davis KAS, Sudlow CLM, Hotopf M. Can mental health diagnoses 
in administrative data be used for research? A systematic review 
of the accuracy of routinely collected diagnoses. BMC Psychiatry 
2016;16:263.
 31 Clinical Practice Research Datalink, 2019. Available: https://www. 
cprd. com
 32 The Phoenix Partnership. ResearchOne, 2019. Available: http://www. 
researchone. org [Accessed 19th Feb 2019].
 33 The Phoenix Partnership. SystmOne, 2019. Available: https://www. 
tpp- uk. com/ products/ systmone [Accessed 19th Feb 2019].
 34 Egton Medical Information Systems. EMIS web, 2019. Available: 
https://www. emishealth. com/ products/ emis- web/ [Accessed 19th 
Feb 2019].
 35 Kontopantelis E, Stevens RJ, Helms PJ, et al. Spatial distribution of 
clinical computer systems in primary care in England in 2016 and 
implications for primary care electronic medical record databases: a 
cross- sectional population study. BMJ Open 2018;8:e020738.
 36 NHS Digital. Accident and Emergency Attendances in England - 
2013-14. Available: https:// digital. nhs. uk/ data- and- information/ 
publications/ statistical/ hospital- accident-- emergency- activity/ 2013- 
14 [Accessed 11th Sep 2019].
 37 NHS Digital. Hospital Episode Statistics, Admitted Patient Care, 
England - 2013-14. Available: https:// digital. nhs. uk/ data- and- 
information/ publications/ statistical/ hospital- admitted- patient- care- 
activity/ hospital- episode- statistics- admitted- patient- care- england- 
2013- 14 [Accessed 11th Sep 2019].
 38 Department of Health. Reference costs 2015–16. London, UK: NHS 
England, 2016.
 39 Curtis L, Burns A. Unit costs of health and social care 2018. 
Canterbury Personal Social Services Research Unit, University of 
Kent; 2018.
 40 National Institute for Health and Care Excellence. Guide to the 
methods of technology appraisal. London: NICE, 2013.
 41 Briggs R, Sculpher M, Claxton K. Decision modelling for health 
economic evaluation. Oxford, UK: Oxford University Press, 2006.
 42 Petrou S, Gray A. Economic evaluation using decision analytical 
modelling: design, conduct, analysis, and reporting. BMJ 
2011;342.
 43 Health Research Authority. Confidentiality Advisory Group, 2019. 
Available: https://www. hra. nhs. uk/ approvals- amendments/ what- 
approvals- do- i- need/ confidentiality- advisory- group
 44 HM Government. The Health Service (Control of Patient Information) 
Regulations 2002, 2019. Available: http://www. legislation. gov. uk/ 
uksi/ 2002/ 1438/ contents/ made
 45 NHS Digital. Independent Group Advising on the Release of Data, 
2019. Available: https:// digital. nhs. uk/ about- nhs- digital/ corporate- 
information- and- documents/ independent- group- advising- on- the- 
release- of- data [Accessed 19th Feb 2019].
 46 Whittlestone J, Nyrup R AA, Dihal K SC. Ethical and societal 
implications of algorithms, data, and artifical intelligence: a roadmap 
for research. London: Nuffield Foundation, 2019.
copyright.
 o
n
 January 13, 2020 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032179 on 24 November 2019. Downloaded from 
